These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37416010)

  • 41. Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection.
    Khazaaleh S; Gonzalez AJ; Alomari M; Wadhwa V; Shah B; Shen B
    Cureus; 2022 Jun; 14(6):e26076. PubMed ID: 35875313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology and Outcomes of Patients With Healthcare Facility-Onset Clostridioides difficile Infection.
    Eberly MD; Susi A; Adams DJ; Love CS; Nylund CM
    Mil Med; 2022 Jul; 187(7-8):e915-e920. PubMed ID: 33772561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During
    Costa DVS; Moura-Neto V; Bolick DT; Guerrant RL; Fawad JA; Shin JH; Medeiros PHQS; Ledwaba SE; Kolling GL; Martins CS; Venkataraman V; Warren CA; Brito GAC
    Front Cell Infect Microbiol; 2021; 11():739874. PubMed ID: 34568098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
    Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
    Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016.
    Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A
    Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
    Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
    [No Abstract]   [Full Text] [Related]  

  • 49. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
    mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
    Mizusawa M; Doron S; Gorbach S
    Drugs Aging; 2015 Aug; 32(8):639-47. PubMed ID: 26233437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patients with
    Shaikh DH; Patel H; Munshi R; Sun H; Mehershahi S; Baiomi A; Alemam A; Pirzada U; Nawaz I; Naher K; Hanumanthu S; Nayudu S
    World J Gastrointest Surg; 2021 Nov; 13(11):1436-1447. PubMed ID: 34950432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
    Pipek B; Valentová H; Fojtík P; Urban O
    Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    Aliment Pharmacol Ther; 2014 May; 39(10):1136-42. PubMed ID: 24641590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
    Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
    Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.
    Bednarska A; Sosińska-Bryła I; Hackiewicz M; Bursa D; Makowiecki M; Porowski D; Horban A
    Przegl Epidemiol; 2022; 77(1):23-33. PubMed ID: 37283245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
    Yu H; Flaster N; Casanello AL; Curcio D
    Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
    Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
    Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low vitamin D level and impact on severity and recurrence of Clostridium difficile infections.
    Abdelfatah M; Nayfe R; Moftakhar B; Nijim A; El Zoghbi M; Donskey CJ; Kandil H; Watkins RR
    J Investig Med; 2015 Jan; 63(1):17-21. PubMed ID: 25479065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiome and mycobiome in inflammatory bowel disease patients with
    Yu S; Ge X; Xu H; Tan B; Tian B; Shi Y; Dai Y; Li Y; Hu S; Qian J
    Front Cell Infect Microbiol; 2023; 13():1129043. PubMed ID: 36814443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.